Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Acquired Immunodeficiency Syndrome: HELP
François Dabis
Based on 12 articles published since 2009
(Why 12 articles?)
||||
Expertise Level
The expertise of François Dabis ranks in the Graphical view (beta)
Work Locations
Details
Most likely:    INSERM France      
2018
  • Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA. · Bristol Medical School, University of Bristol, Bristol, UK. · Division of Infectious Diseases, University of Calgary, Calgary, Canada. · Department of Internal Medicine, University of Cologne, Cologne, Germany. · Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France. · INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France. · Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA. · National Epidemiology Center, Carlos III Health Institute, Madrid, Spain. · Yale University School of Medicine, New Haven, CT, USA. · VA Connecticut Healthcare System, West Haven, CT, USA. · Hospital Clínic- Institut d'Investigacions Biomèdiques Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain. · Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. · INSERM U.1218 Bordeaux Population Health, ISPED, Bordeaux University, Bordeaux, France. · Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Milan, Italy. · Stichting HIV Monitoring, Division of Infectious Diseases, Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands. · HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA. · Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada. · Faculty of Medicine, University of British Columbia, Vancouver, Canada. · Research Department of Infection and Population Health, University College London, London, UK. · Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark. · Center for AIDS Research, University of Washington, Seattle, WA, USA. · Research Department of Infection and Population Health, UCL, London, UK. · Unit of Infectious Diseases, Hospital Sierrallana, Torrelavega, Spain. · Innsbruck Medical University, Innsbruck, Austria. · Pubmed 29334197
2014
  • Centre INSERM U897-Epidémiologie-Biostatistique, ISPED, Université de Bordeaux, Bordeaux, France; Inserm U897, ISPED, Université de Bordeaux, Bordeaux, France; Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; · Centre de Diagnostic et de Recherche sur le SIDA et les Affections Opportunistes, CHU de Treichville, Abidjan, Côte d'Ivoire. · Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Service des Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Côte d'Ivoire. · Centre de Prise en Charge des Personnes vivant avec le VIH, Hôpital du Point G, Bamako, Mali. · Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Centre de Prise en Charge de Recherche et de Formation, CePReF-Aconda-VS, Abidjan, Côte d'Ivoire. · Hôpital de Jour, Service des Maladies Infectieuses et Tropicales, CHU Souro Sanou, Bobo Dioulasso, Burkina Faso. · Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Centre Médical de Suivi de Donneurs de Sang/CNTS/PRIMO-CI, Abidjan, Côte d'Ivoire. · Centre Intégré de Recherches Biocliniques d'Abidjan CIRBA, Abidjan, Côte d'Ivoire. · Laboratoire de Bactériologie-Virologie, Département GC&BA-ESP/UCAD, CHU A Le Dantec, Dakar, Sénégal. · Centre INSERM U897-Epidémiologie-Biostatistique, ISPED, Université de Bordeaux, Bordeaux, France; Inserm U897, ISPED, Université de Bordeaux, Bordeaux, France. · Centre INSERM U897-Epidémiologie-Biostatistique, ISPED, Université de Bordeaux, Bordeaux, France; Inserm U897, ISPED, Université de Bordeaux, Bordeaux, France; Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Département des Sciences Fondamentales et Santé Publique, Université de Lomé, Lomé-Togo. · Pubmed 25128907
2014
  • School of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Connecticut Healthcare System, West Haven, CT, USA, Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, University Hospital Lausanne, Lausanne, Switzerland, Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, Research Department of Infection and Population Health, UCL Medical School, London, UK, INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, Department of Internal Medicine University of Cologne, DE, Vanderbilt University School of Medicine, Nashville, TN, USA, National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, Division of Infectious Diseases, University of Calgary, Calgary, Canada, University of Washington School of Medicine, Seattle, WA, USA, Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany · School of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Connecticut Healthcare System, West Haven, CT, USA, Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, University Hospital Lausanne, Lausanne, Switzerland, Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, Research Department of Infection and Population Health, UCL Medical School, London, UK, INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, Department of Internal Medicine University of Cologne, DE, Vanderbilt University School of Medicine, Nashville, TN, USA, National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, Division of Infectious Diseases, University of Calgary, Calgary, Canada, University of Washington School of Medicine, Seattle, WA, USA, Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany. · School of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Connecticut Healthcare System, West Haven, CT, USA, Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, University Hospital Lausanne, Lausanne, Switzerland, Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, Research Department of Infection and Population Health, UCL Medical School, London, UK, INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, Department of Internal Medicine University of Cologne, DE, Vanderbilt University School of Medicine, Nashville, TN, USA, National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, Division of Infectious Diseases, University of Calgary, Calgary, Canada, University of Washington School of Medicine, Seattle, WA, USA, Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, GermanySchool of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Co · Pubmed 23599235
2010
  • INSERM, U 897, Epidemiology for Cancer Prevention, Bordeaux, France. · Pubmed 20066157
2009
  • INSERM, Unité 897, Centre de Recherche Epidémiologie et Biostatistique, Bordeaux, France. · Pubmed 19916796
Probable:    Universite de Bordeaux      
2014
  • Centre INSERM U897-Epidémiologie-Biostatistique, ISPED, Université de Bordeaux, Bordeaux, France; Inserm U897, ISPED, Université de Bordeaux, Bordeaux, France; Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; · Centre de Diagnostic et de Recherche sur le SIDA et les Affections Opportunistes, CHU de Treichville, Abidjan, Côte d'Ivoire. · Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Service des Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Côte d'Ivoire. · Centre de Prise en Charge des Personnes vivant avec le VIH, Hôpital du Point G, Bamako, Mali. · Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Centre de Prise en Charge de Recherche et de Formation, CePReF-Aconda-VS, Abidjan, Côte d'Ivoire. · Hôpital de Jour, Service des Maladies Infectieuses et Tropicales, CHU Souro Sanou, Bobo Dioulasso, Burkina Faso. · Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Centre Médical de Suivi de Donneurs de Sang/CNTS/PRIMO-CI, Abidjan, Côte d'Ivoire. · Centre Intégré de Recherches Biocliniques d'Abidjan CIRBA, Abidjan, Côte d'Ivoire. · Laboratoire de Bactériologie-Virologie, Département GC&BA-ESP/UCAD, CHU A Le Dantec, Dakar, Sénégal. · Centre INSERM U897-Epidémiologie-Biostatistique, ISPED, Université de Bordeaux, Bordeaux, France; Inserm U897, ISPED, Université de Bordeaux, Bordeaux, France. · Centre INSERM U897-Epidémiologie-Biostatistique, ISPED, Université de Bordeaux, Bordeaux, France; Inserm U897, ISPED, Université de Bordeaux, Bordeaux, France; Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Département des Sciences Fondamentales et Santé Publique, Université de Lomé, Lomé-Togo. · Pubmed 25128907
2010
  • INSERM, U 897, Epidemiology for Cancer Prevention, Bordeaux, France. · Pubmed 20066157
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 12 total) written by François Dabis about Acquired Immunodeficiency Syndrome:

  • Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation. 2018
  • Antiretroviral therapy response among HIV-2 infected patients: a systematic review. 2014
  • Re-testing and misclassification of HIV-2 and HIV-1&2 dually reactive patients among the HIV-2 cohort of the West African Database to evaluate AIDS collaboration. 2014
  • AIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000-2008: hospital-based cohort studies. 2014
  • Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC). 2014
  • Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa. 2012
  • Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2). 2011
  • Very high concentrations of active intracellular phosphorylated emtricitabine in neonates (ANRS 12109 trial, step 2). 2011
  • Evaluation of three sampling methods to monitor outcomes of antiretroviral treatment programmes in low- and middle-income countries. 2010
  • The challenge of AIDS-related malignancies in sub-Saharan Africa. 2010
Show List of Full Article Records
Google Searches

Learn more about François Dabis using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
INSERM France
Universite de Bordeaux
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
INSERM France
2018
  • Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA. · Bristol Medical School, University of Bristol, Bristol, UK. · Division of Infectious Diseases, University of Calgary, Calgary, Canada. · Department of Internal Medicine, University of Cologne, Cologne, Germany. · Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France. · INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France. · Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA. · National Epidemiology Center, Carlos III Health Institute, Madrid, Spain. · Yale University School of Medicine, New Haven, CT, USA. · VA Connecticut Healthcare System, West Haven, CT, USA. · Hospital Clínic- Institut d'Investigacions Biomèdiques Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain. · Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. · INSERM U.1218 Bordeaux Population Health, ISPED, Bordeaux University, Bordeaux, France. · Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Milan, Italy. · Stichting HIV Monitoring, Division of Infectious Diseases, Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands. · HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA. · Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada. · Faculty of Medicine, University of British Columbia, Vancouver, Canada. · Research Department of Infection and Population Health, University College London, London, UK. · Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark. · Center for AIDS Research, University of Washington, Seattle, WA, USA. · Research Department of Infection and Population Health, UCL, London, UK. · Unit of Infectious Diseases, Hospital Sierrallana, Torrelavega, Spain. · Innsbruck Medical University, Innsbruck, Austria. · Pubmed 29334197
2014
  • Centre INSERM U897-Epidémiologie-Biostatistique, ISPED, Université de Bordeaux, Bordeaux, France; Inserm U897, ISPED, Université de Bordeaux, Bordeaux, France; Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; · Centre de Diagnostic et de Recherche sur le SIDA et les Affections Opportunistes, CHU de Treichville, Abidjan, Côte d'Ivoire. · Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Service des Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Côte d'Ivoire. · Centre de Prise en Charge des Personnes vivant avec le VIH, Hôpital du Point G, Bamako, Mali. · Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Centre de Prise en Charge de Recherche et de Formation, CePReF-Aconda-VS, Abidjan, Côte d'Ivoire. · Hôpital de Jour, Service des Maladies Infectieuses et Tropicales, CHU Souro Sanou, Bobo Dioulasso, Burkina Faso. · Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Centre Médical de Suivi de Donneurs de Sang/CNTS/PRIMO-CI, Abidjan, Côte d'Ivoire. · Centre Intégré de Recherches Biocliniques d'Abidjan CIRBA, Abidjan, Côte d'Ivoire. · Laboratoire de Bactériologie-Virologie, Département GC&BA-ESP/UCAD, CHU A Le Dantec, Dakar, Sénégal. · Centre INSERM U897-Epidémiologie-Biostatistique, ISPED, Université de Bordeaux, Bordeaux, France; Inserm U897, ISPED, Université de Bordeaux, Bordeaux, France. · Centre INSERM U897-Epidémiologie-Biostatistique, ISPED, Université de Bordeaux, Bordeaux, France; Inserm U897, ISPED, Université de Bordeaux, Bordeaux, France; Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Département des Sciences Fondamentales et Santé Publique, Université de Lomé, Lomé-Togo. · Pubmed 25128907
2014
  • School of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Connecticut Healthcare System, West Haven, CT, USA, Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, University Hospital Lausanne, Lausanne, Switzerland, Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, Research Department of Infection and Population Health, UCL Medical School, London, UK, INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, Department of Internal Medicine University of Cologne, DE, Vanderbilt University School of Medicine, Nashville, TN, USA, National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, Division of Infectious Diseases, University of Calgary, Calgary, Canada, University of Washington School of Medicine, Seattle, WA, USA, Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany · School of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Connecticut Healthcare System, West Haven, CT, USA, Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, University Hospital Lausanne, Lausanne, Switzerland, Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, Research Department of Infection and Population Health, UCL Medical School, London, UK, INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, Department of Internal Medicine University of Cologne, DE, Vanderbilt University School of Medicine, Nashville, TN, USA, National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, Division of Infectious Diseases, University of Calgary, Calgary, Canada, University of Washington School of Medicine, Seattle, WA, USA, Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany. · School of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Connecticut Healthcare System, West Haven, CT, USA, Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, University Hospital Lausanne, Lausanne, Switzerland, Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, Research Department of Infection and Population Health, UCL Medical School, London, UK, INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, Department of Internal Medicine University of Cologne, DE, Vanderbilt University School of Medicine, Nashville, TN, USA, National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, Division of Infectious Diseases, University of Calgary, Calgary, Canada, University of Washington School of Medicine, Seattle, WA, USA, Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, GermanySchool of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Co · Pubmed 23599235
2010
  • INSERM, U 897, Epidemiology for Cancer Prevention, Bordeaux, France. · Pubmed 20066157
2009
  • INSERM, Unité 897, Centre de Recherche Epidémiologie et Biostatistique, Bordeaux, France. · Pubmed 19916796
Universite de Bordeaux
2014
  • Centre INSERM U897-Epidémiologie-Biostatistique, ISPED, Université de Bordeaux, Bordeaux, France; Inserm U897, ISPED, Université de Bordeaux, Bordeaux, France; Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; · Centre de Diagnostic et de Recherche sur le SIDA et les Affections Opportunistes, CHU de Treichville, Abidjan, Côte d'Ivoire. · Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Service des Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Côte d'Ivoire. · Centre de Prise en Charge des Personnes vivant avec le VIH, Hôpital du Point G, Bamako, Mali. · Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Centre de Prise en Charge de Recherche et de Formation, CePReF-Aconda-VS, Abidjan, Côte d'Ivoire. · Hôpital de Jour, Service des Maladies Infectieuses et Tropicales, CHU Souro Sanou, Bobo Dioulasso, Burkina Faso. · Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Centre Médical de Suivi de Donneurs de Sang/CNTS/PRIMO-CI, Abidjan, Côte d'Ivoire. · Centre Intégré de Recherches Biocliniques d'Abidjan CIRBA, Abidjan, Côte d'Ivoire. · Laboratoire de Bactériologie-Virologie, Département GC&BA-ESP/UCAD, CHU A Le Dantec, Dakar, Sénégal. · Centre INSERM U897-Epidémiologie-Biostatistique, ISPED, Université de Bordeaux, Bordeaux, France; Inserm U897, ISPED, Université de Bordeaux, Bordeaux, France. · Centre INSERM U897-Epidémiologie-Biostatistique, ISPED, Université de Bordeaux, Bordeaux, France; Inserm U897, ISPED, Université de Bordeaux, Bordeaux, France; Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Département des Sciences Fondamentales et Santé Publique, Université de Lomé, Lomé-Togo. · Pubmed 25128907
2010
  • INSERM, U 897, Epidemiology for Cancer Prevention, Bordeaux, France. · Pubmed 20066157
29 Other Locations Show
Yearly article counts 01000401222
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.